Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Genta files appeal against FDA decision on Genasense for CLL

April 11, 2007

Novel series of anticancer compounds disclosed in recent patents

April 11, 2007

Ceflatonin studied in new phase II/III study in CML

April 10, 2007

SuperGen completes sale of remaining Nipent rights

April 10, 2007

Tasquinimod enhances response to androgen ablation in prostate cancer models

April 10, 2007

Novel anticancer compounds reported in recent patent literature

April 10, 2007

Pharmacyclics' NDA for Xcytrin to be filed over protest

April 5, 2007

ChemGenex raises funds to support Ceflatonin development program

April 5, 2007

Recent patents impart new therapeutic agents for cancer

April 4, 2007

Phase II study of LE-SN38 misses primary tumor response endpoint

April 4, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...